Latest news

Can we predict aneuploidy or mosaicism considering blastocyst morphology?

  • 08/12/20

This new research was presented at the last congress of the European Fertility Society that took place on last July. The aim of this study is to identify which embryo features are correlated with higher aneuploidy or mosaicism rates, and if it is possible to predict them.

Read more

Download for free the Guide for women who decide to be a mother without a partner

  • 08/11/20

At Instituto Bernabeu we want to make it easier for women who want to be a mother without a partner. That is why we give away this Guide, which can be downloaded free of charge, to help you in your life project of undertaking motherhood alone

Read more

Comparative analysis of the most precise technique for the chromosomal study of the embryo. Instituto Bernabeu finding to be presented at ESHRE 2020

  • 07/31/20

One of the latest scientific project carried out at Instituto Bernabeu has been accepted at the next European Society for Human Reproduction (ESHRE) congress. The aim of this research was to evaluate the accuracy of niPGT-A by comparing two different chromosome analysis techniques used to study the embryo

Read more

New study by Instituto Bernabeu determines which type of embryo biopsy provides a least damage of the embryo and a higher success rate of the cycle

  • 07/29/20

In the last meeting of reproductive medicine experts, the European Fertility Congress (ESHRE), we presented a new research developed entirely at Instituto Bernabeu clinics. The study focused on how the technique used for the biopsy prior to an embryonic genetic study (pulling and flicking) affected the genetic results, the rate and type of embryonic mosaicism, as well as the success of PGT-A cycles.

Read more

A new study from Instituto Bernabeu relates genetic changes with chromosomal abnormalities in the embryo and the probability of ongoing pregnancy

  • 07/23/20

The enzyme methylenetetrahydrofolate reductase (MTHFR) is involved in the metabolism of folic acid which is an essential nutrient for reproduction and pregnancy. There are studies that relate variants in the MTHFR gene with alterations in the embryo and problems with the pregnancy. The variants C677CT and A1298C are the most relevant. The aim of this study, accepted to be presented in a poster at this year's congress of the European Society of Reproduction ESHRE, was to study the relationship of these genetic changes with chromosomal abnormalities in the embryo and with the probability of pregnancy (ongoing pregnancy rate) after the transfer of chromosomally normal embryos

Read more

A breakthrough in the diagnosis of low ovarian reserve linked to Interleukin-10 levels

  • 07/15/20

A new research from Instituto Bernabeu associates the state of the patient's cytokines with the diagnosis of low ovarian reserve and response. The conclusions of the work were presented in the last edition of the European Society of Human Reproduction and Embryology (ESHRE) congress, which took place between the 6th and 9th of July.

Read more

Instituto Bernabeu and the University of Alicante manage the 9th edition of the Master's Course in Reproductive Medicine

  • 07/14/20

Instituto Bernabeu and the University of Alicante (UA) will manage the 9th edition of the Master's Course in Reproductive Medicine for the 2020-2021 academic year. The aim is to provide experts from the world of health sciences with excellent and comprehensive training in the field of reproductive medicine.

Read more

A new scientific breakthrough on the genetics of the embryo developed at Instituto Bernabeu will be presented at the European Fertility Congress

  • 07/08/20

A new study developed at Instituto Bernabeu has been accepted for presentation at the European Society of Human Reproduction and Embryology (ESHRE) Congress held between the 6th to 8th of July. For this project, 5286 embryos from 1822 cycles between October 2014 and April 2019 were included. The study showed that the segmental alterations were located at the ends (telomeres) of the chromosomes (58.2%). 

Read more

Ten Instituto Bernabeu research projects arouse the interest of the European Society of Human Reproduction and Embryology, ESHRE, in its first virtual congress

  • 07/06/20

From the 5th until the 8th of July Instituto Bernabeu presents studies in the field of reproductive biology, molecular biology, genetics and embryology... during this annual meeting.

Read more

Research carried out at Instituto Bernabeu links the result of the β-hCG with the prognosis of the pregnancy

  • 07/01/20

2020 events conditioned the congress of the European Society of Human Reproduction and Embryology (ESHRE) to be held online for the first time in history. Among different research projects developed at Instituto Bernabeu that its scientific committee has accepted to share with the community, there is a report on the evaluation of the β-hCG pregnancy hormone value as a predictor of the evolution of the pregnancy

Read more

New research from Instituto Bernabeu based on the use of micronized natural progesterone versus GnRH antagonists in egg donation cycles.

  • 06/17/20

Dr. Juan Carlos Castillo will present an Oral Communication at the next ESHRE Meeting of the latest research paper “Natural micronized progesterone versus a GnRH antagonist in egg-donation cycles. An extended experience ”; a new advance to improve medication in egg donors.

The current circumstances have made this scientific event, the most important in the field of Reproductive Medicine, to be held extraordinarily online this year.

Read more

Instituto Bernabeu participates in the creation of the first oficial ultrasound guide for Reproductive Medicine

  • 06/03/20

Instituto Bernabeu has participated in the creation of the Guide to Practical Care of the Obstetric and Gynecological Ultrasound section of the Spanish Society of Obstetrics and Gynecology.

Read more

Upsala Journal of Medical Sciences prints a review carried out by Instituto Bernabeu regarding the role of GnRHa as ovulation induction, more than just to prevent hyperstimulation.

  • 05/27/20

Optimizes and improves cycles for egg donors, oncology patients, women with low reserve, immature oocyte syndrome and empty follicle syndrome

The international medical journal Upsala Journal of Medical Sciences has just published a research paper led by Instituto Bernabeu entitled "Gonadotropin-releasing hormone agonist ovulation trigger — beyond OHSS prevention". It was developed by Instituto Bernabeu gynecologist, expert in ovarian stimulation, Dr. Juan Carlos Castillo with the participation of Thor Haahr, María Martínez-Moya and Peter Humaidan. The goal of this review is to present the advantages of the gonadotropin-releasing hormone agonist (GnRHa) trigger in ovarian stimulation during reproductive medicine treatment. It highlights that its role goes beyond the prevention of ovarian hyperstimulation syndrome (OHSS).

Read more

Invitation from the Peruvian Fertility Society: WEBINAR advances in assisted reproduction

  • 05/19/20

On Thursday the 21st of May, the doctors of Instituto Bernabeu, Dr. Joaquin Llácer and Dr. Juan Carlos Castillo, have been invited to give a webinar to the doctors of the Peruvian Society of Fertility.

Read more

The covid-19 coronavirus detection tests will be included free of charge in our Pregnancy Guarantee Programs

  • 05/13/20

Our Pregnancy and Childbirth Guarantee Program was the first to emerge in Europe, now 6 years ago. It was born with the vocation of providing certainty in success and releasing patients from worries; patients are offered full coverage of all medical assistance they may require in their reproductive treatment until the pregnancy is achieved, eliminating uncertainty until the birth of their child, or they would receive a full reimbursement.

 

Read more

DOWNLOAD OUR FREE NEWSLETTER

  • 05/06/20

Looking for reliable, enjoyable and proven articles? At this moment of quarantine due to the coronavirus, we’ve made the latest issue of our magazine available so that you can conveniently download it at home clicking on the following link.

Read more

Dr Rafael Bernabeu will conduct this Wednesday the Covid-19 Webinar: How and when can I start or retake my fertility treatment?

  • 04/28/20

Instituto Bernabeu’s Head Doctor, Dr Rafael Bernabeu, will conduct this Wednesday 29th of April the webinar Covid-19: How and when can I start or retake my fertility treatment? Dr Bernabeu will answer live through YouTube Live, all questions related to this pandemic and how affects fertility treatments from 10am and from 11am to all non-Spanish patients in English.

Read more

New IB Newsletter: 27th OF APRIL Resume the reproductive medicine activity

  • 04/25/20

The new Instituto Bernabeu Group newsletter is now available. 27th OF APRIL Resume the reproductive medicine activity.

 

Read more

Dr. Moliner conducts a webinar for SEF gynecologists to show, from home, how to perform 3D uterine ultrasounds

  • 04/21/20

The Fertility Image group of the Spanish Fertility Society (SEF) coordinated by Instituto Bernabeu doctor Belén Moliner has organized a webinar for this Wednesday, April 22, to show updates on ultrasound technology.

Read more

New IB Newsletter: FERTILITY VIDEO CONSULTATION

  • 04/16/20

The new Instituto Bernabeu Group newsletter is now available. The entire team of specialists in Reproductive Medicine of Instituto Bernabeu is at your disposal to offer you your fertility study visit through videoconference.

Read more

EXPERT TASK FORCE COVID19

  • 04/14/20

The difficult situation caused by the Covid-19 pandemic, which affects both men and women in the andrological, gynecological, obstetric and reproductive spheres, is generating a multitude of information, at times confusing, that requires analysis and study to manage it properly.

Read more

Digital meet-ups with our specialists

  • 04/06/20

In these extraordinary times in which we are living, in isolation, we want to be even closer to our patients so they know we remain at their disposal. If you are not yet a patient, but you would like to get to know us, you can also send us your questions.

 

Read more

Online fertility consultations with video conferencing, so that isolation doesn’t stop your life plans

  • 04/02/20

We know that there are things that cannot wait, and distance and isolation should not be an obstacle. We offer you online fertility consultation, hand in hand with our specialists in the most advanced reproductive medicine. If it is not possible to see each other in person, through personalized attention via videoconference, you can carry out your first fertility appointment online or prepare the next steps of your case if you are already a patient. New technologies bring us closer and help us move forward with our personal goals.

Read more

We are open for your needs: gynecology, fertility or pregnancy

  • 03/31/20

Sometimes, gynecological health requirements or pregnancy needs do not know of confinements and cannot wait, that is why we have especially enabled a few hours to be able to attend to your needs in person. You can carry out gynecological, fertility and pregnancy follow up consultations, as well as diagnostic or laboratory tests that may be required for a correct diagnosis.

Read more

Instituto Bernabeu has put at the health authorities´s disposal all its medical and surgical material to combat the coronavirus

  • 03/28/20

Given the seriousness of the situation that our country and its medical professionals are facing to combat the pandemic caused by covid-19, all the clinics of Instituto Bernabeu have given to the health authorities all their medical and surgical equipment that may be necessary to combat coronavirus. 

Read more

New IB Newsletter: Coronavirus COVID-19. Uptading regarding our activity status

  • 03/21/20

The new Instituto Bernabeu Group newsletter is now available. Coronavirus COVID-19. Uptading regarding our activity status.

Read more

Instituto Bernabeu speaks to future biotechnologists at Miguel Hernández University about their role in reproductive medicine

  • 03/12/20

Instituto Bernabeu and the role of its genetics and molecular biology laboratory have been used to instruct biotechnology students at Miguel Hernández University (UMH) about the day-to-day demands of their future profession. The talk took place within the framework of the 8th Employment in Biotechnology event, to which the clinic was invited.

Read more

Instituto Bernabeu participates in Life by Merck, a scientific gathering of infertility experts held in Valencia

  • 03/09/20

Instituto Bernabeu played a leading clinic role in a scientific gathering of assisted reproduction experts organised by Merck in Valencia. Dr Andrea Bernabeu, Co-Director of Instituto Bernabeu and Coordinator of the Genetics and Reproduction Assessment Unit; Dr Jorge Ten, Director of the Embryology Unit; and Dr Juan Carlos Castillo, a gynaecologist and expert in ovarian hyperstimulation syndrome at Instituto Bernabeu, all attended the event.

Read more

Instituto Bernabeu addressed the male factor at the first edition of an event on assisted reproduction held in Toledo

  • 03/03/20

Ongoing training and participation in congresses is part of the day-to-day work routine at Instituto Bernabeu. One such example this month was the first edition of the Assisted Reproduction Event held in Toledo (Spain) on 21st and 22nd February. Mónica Aparicio, an embryologist at Instituto Bernabeu in Madrid, participated in the gathering of experts where male factor and DNA fragmentation issues were addressed. Her intervention covered the techniques that are performed at the clinic.

Read more

At the third edition of the symposium on controversial issues in the field of reproductive and perinatal medicine, Dr Llaneza highlights the role of anti-Müllerian hormone when personalising stimulation

  • 02/26/20

Instituto Bernabeu participated in the third edition of the symposium on controversial issues in the field of reproductive and perinatal medicine which was held in Madrid in late January. Dr Ángela Llaneza, a specialist in reproductive medicine at the clinic in Madrid, participated in the event by giving a lecture entitled ‘Anti-Müllerian Hormone (AMH) and reproduction guidance’.

Read more

The Manager of the Embryology Unit at Instituto Bernabeu addresses oocyte vitrification on the Master's Course in Human Reproduction at Complutense University

  • 02/19/20

The Manager of the Embryology Unit at Instituto Bernabeu, Dr Jorge Ten, has given a lecture on the Master’s Course in Human Reproduction organised by Complutense University in Madrid (UCM) and the Spanish Fertility Society (SEF). The doctor has been actively involved in course for over a decade. Dr Ten addressed the issue of oocyte vitrification. Instituto Bernabeu is a groundbreaking clinic in this field with over fifteen years of experience of vitrification of both gametes and embryos. Practices such as these need to be performed under a robust vitrification programme and by experienced embryologists. The Master's Course, in which Instituto Bernabeu plays an active role, trains students in highly specialised reproductive medicine skills and updates their scientific knowledge.

Read more

All the clinics in the Instituto Bernabeu group have been awarded the ISO 14001:2015 Environmental Management System Certificate

  • 02/18/20

The Instituto Bernabeu Group has obtained the ISO 14001:2015 Environmental Management System Certificate in all its clinics; Alicante, Madrid, Palma de Mallorca, Albacete, Cartagena, Elche and Benidorm.

Read more

Experts from Instituto Bernabeu give master classes about ovarian reserve and stimulation on the UA and IB Master's degree in Reproductive Medicine

  • 02/13/20

 Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu and expert in poor ovarian reserve; Dr Juan Carlos Castillo, a specialist in ovarian stimulation; and Cristina García-Ajofrín, a gynaecologist at IB in Madrid and an expert in uterine causes of infertility, have given three master classes to students on the University of Alicante and Instituto Bernabeu Master's degree in Reproductive Medicine.

Read more

Dr Rafael Bernabeu highlights the importance of assessing all patients’ ovarian reserve in a speech at the Obstetrics and Gynaecology Society Congress

  • 02/12/20

A woman’s ovarian reserve is the number of viable oocytes that she has in her ovaries at any given time. This figure conditions the quantity of ova that can be retrieved during in vitro fertilisation treatment. As a woman ages, her ovarian reserve decreases and this is why the Medical Director at Instituto Bernabeu, Dr Rafael Bernabeu, has emphasised the importance of this factor and encouraged both experts in the field and patients to be keenly aware of this before it is too late.

Read more

Instituto Bernabeu presents research into the role of cytokines in implantation failure at the ESHRE Campus in Milan

  • 02/06/20

Instituto Bernabeu participated in a gathering of experts at the ‘Endometriosis and infertility: the extent of the problem’ ESHRE Campus held in Milan on 23rd and 24th January 2020. The scientific event, organised by the European Society of Human Reproduction and Embryology’s endometriosis and endometrial disorders work group, selected research work carried out by Instituto Bernabeu as a candidate for the best poster award. Dr Belén Moliner, the clinic's expert in endometriosis, attended the meeting in order to answer questions about the research work: ‘The inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure with endometriosis and without it.’

Read more

Instituto Bernabeu researchers study the impact of the male factor on embryo mosaicism

  • 02/06/20

Instituto Bernabeu researchers have studied the impact of the male factor on embryo mosaicism or cases of embryos with some normal cells and some chromosomally abnormal cells. It is one of the reasons for implantation failure but the factors that cause it remain unclear. The aim of the study was to assess which male factors could have an impact on embryo mosaicism rates.

Read more

Instituto Bernabeu studies whether or not retaining fertilisation failure or abnormal fertilisation oocytes in culture is advisable

  • 02/04/20

The Embryology and Reproductive Medicine Units at Instituto Bernabeu are leading research aimed at determining if a reasonable number of good quality blastocysts (embryos on days 5 to 6 or development prior to implantation) can be retrieved following culture and observation of oocytes that have not fertilised correctly. In in vitro fertilisation laboratories, around 20% of inseminated oocytes suffer fertilisation failure and 3% of oocytes fertilise abnormally.

Read more

Instituto Bernabeu analyses if probiotics for vaginal health improve results in assisted reproduction treatment

  • 02/03/20

Instituto Bernabeu has undertaken a research project that aims to analyse if using probiotics could improve pregnancy rates in assisted reproduction treatment. To this end, the clinic has performed a study involving a group of patients with a recurrent implantation failure (RIF) diagnosis, plus another group of patients with no such diagnosis.

Read more

At a medical event in Italy, Instituto Bernabeu addresses the strict processes that it adheres to for egg and sperm donation

  • 01/29/20

Instituto Bernabeu has participated in a professional event for general health and reproductive medicine specialists. The clinic addressed the procedures it adheres to for egg and sperm donation, in addition to means of achieving improved results. The congress was entitled ‘Means of diagnostic and therapeutic healthcare in assisted reproduction procedures and synergies between specialists in the field.’ Instituto Bernabeu addressed the requirements for and access to heterologous artificial insemination through egg donation, sperm donation and embryo adoption.

Read more

Instituto Bernabeu uses next-generation sequencing to understand unknown causes of infertility

  • 01/27/20

The genetics laboratory at Instituto Bernabeu is using next-generation sequencing to find out what is behind unknown causes of sterility. In 2020, Instituto Bernabeu will continue with work on the research into this subject that it started in 2018. Instituto Bernabeu points out that next-generation sequencing can be used to work out what causes sterility when other conventional clinical diagnoses techniques cannot.

Read more

Instituto Bernabeu research looks into whether or not ovarian stimulation factors can affect oocyte morphology and membrane breakage types during ICSI

  • 01/22/20

Instituto Bernabeu research aimed to determine if any ovarian stimulation factors can be linked to oocyte morphology and to the type of membrane breakage when intracytoplasmic spermatozoa injection (ICSI) is performed. This assisted reproduction technique is routinely used in in vitro fertilisation (IVF) laboratories. It has the huge advantage of providing a helping hand when male patients suffer from severe male factors and it stops sperm counts from being a limitation. However, the main disadvantage is that the results depend to a large degree on the operator performing the technique. Although specialists are currently able to perform the process securely, there are some variations in the results that they obtain. Differences between oocytes in ICSI are observed even when an egg donation programme is used.

Read more

New IB Newsletter: Microbiome analysis in patients with embryo implantation failure

  • 01/21/20

The new Instituto Bernabeu Group newsletter is now available. Microbiome analysis in patients with embryo implantation failure.

Read more

Instituto Bernabeu in Cartagena organises a medical event to address progress in treatment of uterine fibroids

  • 01/15/20

Instituto Bernabeu in Cartagena is organising a scientific event to address progress in the treatment of uterine fibroids. The event will be held on Friday, 31st January in the graduation room at the Polytechnic University in Cartagena. This is just one of many scientific events that the clinic regularly organises at its Cartagena branch. The purpose of the events is to improve knowledge of reproductive health.

Read more

Ovarian rejuvenation: an opportunity for young patients suffering from premature menopause

  • 01/09/20

Instituto Bernabeu is set to employ a new technique that helps women under 35 years of age to have children with their own ova. These women are otherwise compelled to turn to egg donation

Read more

The Instituto Bernabeu Foundation is one of the province’s most active social welfare foundations and has contributed almost €200,000 towards dealing with social issues

  • 12/23/19

Instituto Bernabeu's social welfare entity invests over €123,000 in courses of treatment for patients who have limited financial resources. This is over 70% of the €176,000 total spend. It donates €33,500 to NGOs, €14,200 to science and research and €10,000 to student scholarships.

Read more

Instituto Bernabeu travels to Portugal to address cases of poor responders and strategies for improving patients’ prognoses

  • 12/18/19

Instituto Bernabeu’s participation in events held in Portugal on 4th and 5th December focused on poor responders and new strategies to help women achieve a pregnancy.

Read more

Instituto Bernabeu analyses if the number of ova obtained following stimulation has an impact on embryo quality

  • 12/16/19

Does the number of oocytes obtained following ovarian puncture have an impact on embryo quality? This is the question that a team of researchers from the Embryology Departments at Instituto Bernabeu in Alicante and Albacete and the genetics laboratory at Biotech asked themselves as they proceeded to study the results obtained in almost 400 cycles of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). The research work was presented in poster format at the Association for the Study of Reproduction Biology (ASEBIR) Congress, a gathering attended by leading global experts. The research was based on the relationship between the number of oocytes obtained following ovarian puncture and the results of IVF treatment.

Read more

Dr Rafael Bernabeu addresses the uterine factor as a cause of recurrent pregnancy loss at SEGO

  • 12/11/19

Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, gave a speech within the framework of the ‘Review and updated handling of recurrent pregnancy loss’ course held in Madrid. The event was organised by the Spanish Society of Gynaecology and Obstetrics (SEGO).

Read more

Instituto Bernabeu investigates the factors that may affect successful embryo transfer

  • 12/10/19

A team of researchers from the Embryology and Reproductive Medicine Units at Instituto Bernabeu in Madrid and Alicante have completed a study of the factors that may have the greatest impact on embryo transfer rates following a cycle of assisted reproduction. The research work was presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in late October in Cáceres.

Read more

An Instituto Bernabeu study analyses if ovarian stimulation can alter the risk of aneuploidies and mosaicism in embryos

  • 12/05/19

The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.

Read more

An Instituto Bernabeu research project demonstrates that the aneuploidy and mosaicism rates in blastocysts is similar in vitrified oocytes and fresh oocytes

  • 12/03/19

Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.

Read more

Instituto Bernabeu obtains the QH* Excellence in Healthcare accreditation

  • 11/28/19

Instituto Bernabeu’s strive for excellence is clearly marked out in a meticulous work method and implementation of the most demanding healthcare and process quality controls with the aim of always achieving excellent results. The healthcare that patients are given is endorsed by certifications and accreditations awarded to the clinic by independent entities. Instituto Bernabeu Group has recently been awarded the QH* accreditation. It entails not only a renewal of the Quality Healthcare (QH) certification, but also an additional, higher level that has been driven by the ‘increase in the validity of certain certifications’, as highlighted by the Institute for Development and Integration of Health (IDIS), the accrediting organism.

Read more

Merck features Instituto Bernabeu research work on the efficiency of double stimulation as presented at the ESHRE congress

  • 11/27/19

Instituto Bernabeu gave an oral communication at the European Society of Human Reproduction and Embryology (ESHRE) Congress entitled ‘The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study.’ This study is included in the articles that Merck has featured in its specialist journal focussing on fitting publications that is released following the scientific gathering focussing on fitting publications.

Read more

Instituto Bernabeu studies if mosaic segmental aneuploidy embryos affect pregnancy rates

  • 11/25/19

Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres and presented a study about the effect that segmental chromosomal aneuploidies have on the embryo.

Read more

Nine pieces of Instituto Bernabeu research work at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres

  • 11/21/19

Once again this year, Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress. It was held in Cáceres from 23rd to 25th October 2019. Nine items of research work performed by the Embryology Unit and the Molecular Biology and Genetics Department were presented at the national congress. It is the most significant congress of its kind in the field of reproduction biology.

Read more

Instituto Bernabeu presents its pioneering research on the impact of assisted reproduction treatment at the microbiome congress in Milan

  • 11/13/19

Instituto Bernabeu attended the World of Microbiome Pregnancy, Birth and Infancy congress held in Milan, Italy from 31st October to 2nd November. Dr Belén Lledó, Scientific Director of IBBiotech presented Instituto Bernabeu’s pioneering research into the impact of the vaginal microbiome on the results of assisted reproduction treatment.

Read more

Endometrial receptivity workshop moderated by Dr Llácer during the clinical gathering about reproduction organised by Ferring in Valencia

  • 11/12/19

Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, moderated the Endometrial Receptivity Workshop held within the framework of the 4th Clinical Workshops on Reproduction Medicine organised by Ferring and held in Valencia on 8th and 9th November.

Read more

Instituto Bernabeu researches the effectiveness of beginning ovarian stimulation protocols in ova donors irrespective of the stage of the menstrual cycle

  • 10/30/19

Instituto Bernabeu has submitted a pilot study involving ova donors to the European Society of Human Reproduction and Embryology (ESHRE). It researches differences in results when conventional ovarian stimulation protocols are applied in comparison with new, no fixed time stimulation protocols that do not take the stage of the menstrual cycle into account. The research entailed an analysis of ova donation cycles which was performed over ten months. It compared stimulation beginning on days 1 to 3 with ovarian stimulation that had no fixed time from day 4 onwards.

Read more

The Rafael Bernabeu Social Welfare Foundation has awarded 10,000 euros to four Medicine and Biotechnology students who have limited financial resources

  • 10/29/19

The Rafael Bernabeu Social Welfare Foundation has published the results of the 2018-2019 scholarships awards. The scholarships provide Medicine, Nursing, Biology and Biotechnology students in Spain with financial support in order boost their studies. On this occasion, further to assessment of all the applications that were received, the Awards Committee chose to award four students the scholarships worth a total of 10,000 euros. 

Read more

Instituto Bernabeu represented by two genetics research projects at the ASRM reproductive medicine congress in North America

  • 10/23/19

Instituto Bernabeu participated in the 75th edition of the American Society for Reproductive Medicine (ASRM) congress held from 12th to 16th October in Philadelphia. It is one of the leading congresses in the world both in terms of the number of participants and in terms of the quality of the work that is presented there. Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, was the clinic representative at the global gathering of experts attended by 9,300 people from 94 countries. It is a not-to-be-missed event in the field.

Read more

Video interview with the speakers of the Instituto Bernabeu International Conference on Advances in Reproductive Medicine

  • 10/16/19

The recent international congress Meeting The Experts provided relevant reviews and information on the latest scientific advances in the treatment of reproductive problems. We were able to interview all the speakers that clarified these aspects. Here are all the videos of the interviews to broaden and complete their contribution.

Read more

Dr Bernabeu addresses medical and healthcare aspects of cross-border reproductive medicine at the University of Alicante

  • 10/15/19

Dr Rafael Bernabeu, Medical Director of Instituto Bernabeu, has addressed medical and healthcare aspects of cross-border reproductive medicine in a gathering of experts in law organised by the University of Alicante (UA).  The seminar, entitled ‘Multi-disciplinary outlooks for studying healthcare in cross-border reproduction’, was held on 23rd September and gynaecologist Dr Bernabeu delivered the specialist’s point of view on the subject. The event was organised by the Department of Civil Law and it was attended by full professors and associate professors in Sociology and Civil Law.

Read more

IBBiotech research into the genetic variants associated with ovarian response is championed in the Pharmacogenetics and Genomics Journal

  • 10/08/19

Pharmacogenetics and Genomics, a specialist journal, recently published Instituto Bernabeu research work into ovarian reserve and pharmacogenetics, a subject in which the clinic is a leading entity and pioneer. The research was managed by Dr Belén Lledó, Scientific Director of Instituto Bernabeu Biotech, and it addressed the relevance of individual screening of the genetic variants in terms of ovarian response prediction. The aim was to determine if the polymorphisms in some genes involved in ovarian follicle maturation can predict ovarian response.

Read more

Instituto Bernabeu research investigates the impact of the vaginal microbiome on assisted reproduction treatment results

  • 10/03/19

The Journal of Assisted Reproduction and Genetics (JARG) has cited the conclusions that were reached during the research

Read more

Instituto Bernabeu brings the third edition of the international Meeting the Experts event to a close

  • 09/30/19

Instituto Bernabeu has brought the third edition of the international Meeting the Experts event for specialists in the field of reproductive medicine (27th and 28th September) to a close. The event was held in the Alicante facilities and 140 experts including gynaecologists, geneticists, biologists, molecular biologists, pharmacists and artificial intelligence specialists from China, USA, Australia, Israel, Belgium, Norway, Denmark, England, Italy and Switzerland met there to exchange knowledge and experiences.

Read more

Dr Llácer addresses the profile of patients with poor ovarian response at the Next Now Theramex international gathering in Valencia

  • 09/20/19

Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, participated in Next Now Theramex Fertility held in Valencia on 20th and 21st September. International experts in the field attended the professional event. Dr Llácer, who is a gynaecologist, addressed the impact of genetic polymorphisms on ovarian response. Poor ovarian reserve is one of the most common issues in the field of reproductive medicine and Dr Llácer is a renowned specialist in this area. He manages the department dedicated to this issue at Instituto Bernabeu.

Read more

Instituto Bernabeu researches new ways of optimising oocyte retrieval during ovarian stimulation in donation cycles

  • 09/18/19

Instituto Bernabeu has submitted research work about optimisation of ovarian stimulation in oocyte donation cycles to the European Society of Human Reproduction and Embryology (ESHRE). The research involves using oral progesterone instead of the GnRH antagonist, the alternative pharmaceutical drug that has traditionally been used to control when ovulation takes place. The main advantage of this strategy is how easy it is for patients because it entails fewer injections.

Read more

Dr Jorge Ten joins a workshop on embryo culture held in Valencia

  • 09/17/19

Dr Jorge Ten, Manager of the Embryology Unit at Instituto Bernabeu, will participate today, Tuesday 17th September, in a CooperSurgical workshop held in Valencia and entitled ‘Experiences using LifeGlobal Total LP (5mg) Culture Media’. The event on embryo culture brings together embryology managers so that they can present their experience and most recent results with this embryo culture and transfer medium.

Read more

The American Journal of Assisted Reproduction and Genetics references research work on fluorescence in situ hybridisation sperm analyses and the results obtained in assisted reproduction techniques

  • 09/12/19

The August 2019 issue of the Journal of Assisted Reproduction and Genetics (JARG) referenced research work about abnormal sperm analysis using the FISH (fluorescence in situ hybridisation) diagnosis technique and in which Instituto Bernabeu is participating. This specialist journal, which is published by the American Society of Reproductive Medicine (ASRM), accepted the research on the use of FISH in assisted reproduction techniques which involves analysis of part of the chromosomal make-up of spermatozoa.

Read more

Instituto Bernabeu research reveals similarities between pregnancy results using Embryoglue® and other conventional culture media

  • 09/11/19

Instituto Bernabeu has submitted research work to the European Society of Human Reproduction and Embryology (ESHRE), the leading worldwide entity in the field of reproductive medicine. The purpose of the research was to understand if using Embryoglue® as the culture medium for embryo transfer to the mother's uterus improves results.

Read more

Instituto Bernabeu research confirms that ova vitrification does not affect the aneuploidy and mosaicism rate in embryos

  • 09/05/19

Instituto Bernabeu is unrelenting in its research work and its trials are featured in leading congresses in the field of reproductive medicine. 

Read more

Instituto Bernabeu has opened its seventh reproductive medicine clinic in Palma de Mallorca

  • 09/02/19

Instituto Bernabeu’s seventh reproductive medicine clinic has opened in Palma de Mallorca. It is located in Avenida de Aragón, number 8, right in the commercial heart of Mallorca, opposite El Corte Inglés. The clinic specialises in personalised solutions and courses of fertility treatment that have been designed to suit each patient. Its branch in Mallorca uses the very latest developments in the field of genetics and reproductive medicine. Its treatment units, such as the Poor Ovarian Reserve Unit and Embryo Implantation Failure Unit are internationally renowned.

Read more

A further year of scientific collaboration and success at ESHRE 2019 for Instituto Bernabeu

  • 07/19/19

For a further year, the European Society of Human Reproduction and Embryology (ESHRE) has summoned a broad group of specialists from Instituto Bernabeu to take part in their scientific round table discussions and debate groups concerning infertility at the largest reproductive medicine and embryology scientific conference held in 2019. Our clinic experts, who contributed their own scientific papers, have thus collaborated in the development of reproductive medicine for a further year.

Read more

New IB Newsletter: Instituto Bernabeu's genetic laboratory achieves the highest accreditation for the PGT-A test

  • 07/11/19

The new Instituto Bernabeu Group newsletter is now available. Thanks to a flawless technical test and a highly regarded report, our embryo PGT-A (pre implantation genetic test) screening was awarded the top score.

 

Read more

Instituto Bernabeu and the University of Alicante manage the 8th edition of the Master's Course in Reproductive Medicine

  • 07/10/19

Instituto Bernabeu and the University of Alicante (UA) will manage the 8th edition of the Master's Course in Reproductive Medicine for the 2019-2020 academic year. The aim is to provide experts from the world of health sciences with excellent and comprehensive training in the field of reproductive medicine.

Read more

Closing ceremony for the 7th Reproductive Medicine Master's Degree by UA held at Instituto Bernabeu

  • 07/09/19

Students from the 7th Reproductive Medicine Master's Degree by University of Alicante (UA) and Instituto Bernabeu have concluded their 2018/2019 course with a closing ceremony held at the clinic's premises.

Read more

Instituto Bernabeu to gather worldwide reproductive medicine experts at the III International Meeting the Experts conference to be held in September

  • 07/02/19

Next September 2019 will see a number of renowned, worldwide experts in the different reproductive medicine areas meet at Instituto Bernabeu's III International Meeting the Experts conference. This triennial event is aimed at sharing new fertility related developments and knowledge with the purpose of attaining a renewed approach concerning the most important challenges facing reproductive medicine.

Read more

Instituto Bernabeu has participated in several expert congresses during the month of June

  • 06/20/19

Instituto Bernabeu undertakes vital healthcare work which is supplemented by its participation in congresses and both national and international events. One of this month's most relevant event took place in Cordoba. The 7th SEF National Meeting of Groups of Interest was held on 7th and 8th June. Every two years, the Spanish Fertility Society brings together experts in assisted reproductive medicine in order to share updated ideas and make new contributions across various fields.

Read more

The PGT-A test performed by the Instituto Bernabeu genetics laboratory is awarded the highest possible mark by a European evaluator

  • 06/18/19

The genetics laboratory at Instituto Bernabeu has been awarded the highest possible mark in an assessment of its PGT-A genetics test by an external and independent European organism. The assessment was performed anonymously on 56 European laboratories. The PGT-A test assesses if the embryo is chromosomally normal or aneuploidy. It is recommended for women who are older when having children; women who have a background of recurrent pregnancy loss; and women who have suffered from implantation failure. This test is also recommended for couples who have chromosomal abnormalities.

Read more

Nine items of Instituto Bernabeu research work present at ESHRE, the leading European congress on fertility

  • 06/11/19

Leading experts worldwide in the field of infertility will gather in Vienna in June. The event is unmissable for Instituto Bernabeu since the clinic will play an active role and will make research work developed by the clinic public. 

Read more

New IB Newsletter: See you at ESHRE!!

  • 06/06/19

The new Instituto Bernabeu Group newsletter is now available. Our group will be actively present at the 35th edition of ESHRE in June. The scientific committee has accepted 9 clinical studies borne of the team of human resources at Instituto Bernabeu based on our research work that focuses on poor ovarian reserve and embryo implantation failure.

Read more

Dr Jorge Ten participates in a panel of experts for developing strategies to treat with patients who have a difficult prognosis

  • 05/28/19

Dr Jorge Ten, Director of the Embryology Unit, participated in a gathering of specialists who debated the main trends in terms of techniques and protocols for treating patients who have a difficult prognosis.

Read more

“Save the date”: “Meeting the Experts” 3rd Edition has already been scheduled.

  • 05/13/19

The next 27th and 28th September will take place the 3rd Edition of "Meeting the Experts", the international reproductive medicine conference organized by Instituto Bernabeu.

Read more

Instituto Bernabeu in Albacete addresses updates in reproductive medicine on the Master's Course in Primary Healthcare at the University of Castilla La Mancha

  • 05/10/19

Instituto Bernabeu has participated in the first edition of the Master's Course in Primary Healthcare at the University Of Castilla La Mancha (UCLM) with an intervention on latest developments in the field of reproductive medicine. The specialist training course is aimed at general practitioners, resident doctors and nursing students and its objectives include increasing participants’ capacity to resolve most of the problems presented by patients who request appointments with their general practitioner, the most proximate level of healthcare. The Master's Course includes updates on the latest developments in terms of diagnosis and treatment in primary healthcare. It is for this reason that gynaecology and reproductive medicine play a significant role.

Read more

Training session on vitrification and devitrification by our Head of reproductive laboratory in IB Madrid

  • 05/09/19

Leyre Herrero, our Head of Human Biology laboratory in Instituto Bernabeu Madrid, will lead a practical theoretical workshop this Thursday where the protocol Kitazato on vitrification and devitrification will be addressed. The training session will take place in Marbella at the HC International Hospital.

Read more

Instituto Bernabeu obtains Quality Clinic status on the Autonomous Community of Valencia Health Clinic Official Register

  • 05/06/19

Instituto Bernabeu has been included as a Quality Clinic on the Autonomous Community of Valencia Official Register of Health Clinics. This means that the clinic has been included on the Autonomous Community of Valencia Register of Quality Certifications for Health Clinics, Services and Establishments. It covers, on the one hand, the ISO 9001:2015 certification that the clinic was awarded in January 2016 for ‘Provision of assisted reproduction clinic healthcare, gynaecology consultations and pregnancy control. Performing molecular biology, andrology laboratory, semen bank, oocyte bank and embryo bank activities.’ On the other, the Autonomous Community Register has added UNE-EN 179006:2013 for ‘Management of patient safety risks’, awarded in December 2015.

Read more

Instituto Bernabeu research selected as one of the best oral presentations at the 2nd Human Genetics Interdisciplinary Congress

  • 04/25/19

Research that was carried out by the Genetics Unit at Instituto Bernabeu Biotech and entitled ‘Mosaic segmental aneuploidies in trophectoderm cells do not affect pregnancy rates in cycles of in vitro fertilisation (IVF)’ has been selected as one of the best oral presentations at the 2nd Human Genetics Interdisciplinary Congress held in Madrid between 3rd and 5th April 2019.

Read more

Instituto Bernabeu presents research work on the impact of mitochondrial DNA when predicting an embryo's ability to implant at the 18th Congress of the Pre-implantation Genetic Diagnosis International Society

  • 04/16/19

The Genetics Department at Instituto Bernabeu was present at the 18th International Conference on pre-implantation genetics organised by the Pre-implantation Genetic Diagnosis International Society (PGDIS) and held in Geneva (Switzerland) between 15th and 18th April. Leading experts in reproductive biology, genetics and embryology met at the event which addressed development of pre-implantation genetic testing (PGT) technology.

Read more

The Medical Co-Director of Instituto Bernabeu addresses poor ovarian response at the National Fertility Congress in Italy

  • 04/10/19

Medical Co-Director of Instituto Bernabeu, Dr Joaquín Llácer, and Dr Paolo Cirillo participated in the 2nd National Congress of the Reproductive Medicine Foundation of Italy (PMA) held in Florence on 21st and 22nd March. Dr Llácer, an expert in poor ovarian reserve, gave a conference delivered to specialists in assisted reproduction that addressed the ‘Challenges of treating patients with poor ovarian response.’ 

Read more

The embryology laboratory at Instituto Bernabeu attends the Human Reproduction Refresher event held in Cuenca

  • 04/03/19

Instituto Bernabeu participated in the 20th Human Reproduction Event held in Cuenca on 21st and 22nd March and organised by the European Fertility Institute. Reproductive medicine professionals from clinics in Madrid attended the event. The Head of the In Vitro Fertilisation (IVF) Laboratory at Instituto Bernabeu in Madrid and Instituto Bernabeu biologist, Iván Ochando, attended the event where participants discussed, debated and were updated on matters within the field of assisted human reproduction.

Read more

Instituto Bernabeu in Albacete addresses gynaecological ultrasound scans on the Master's Course in Primary Healthcare at the University of Castilla La Mancha

  • 04/01/19

Instituto Bernabeu in Albacete participated in the Gynaecological Ultrasound Scan Workshop organised by the University of Castilla La Mancha within the framework of its Master's Course in Primary Healthcare. María Antonia López Rubio, a doctor at the clinic in Albacete, was responsible for teaching some of the finer details of clinical practice at Instituto Bernabeu to students on the specialist training course.

Read more

The Scientific Director of Instituto Bernabeu Biotech addresses the importance of genetics at the 1st Understanding Disability Scientific Event held at UMH

  • 03/29/19

The Scientific Director of Instituto Bernabeu Biotech, Dr Belén Lledó, gave a conference entitled ‘The importance of genetics in early diagnosis’ within the framework of the 1st Scientific Event ‘Understanding Disability: the importance of early diagnosis in intellectual disability and neurodevelopmental disorders’ held at Miguel Hernández University (UMH) in Elche. The gathering was organised by the Tempe/ASPA Disability and Employability Chair at UMH. Dr José Antonio Ortiz, Head of the Molecular Biology Department at Instituto Bernabeu, was also present and moderated the lecture.

Read more

Doctors Llácer, Castillo and Ten selected as scientific research reviewers for the world's most important infertility congress

  • 03/27/19

The congress sponsored by the European Society of Human Reproduction and Embryology (ESHRE) and the world’s most important gathering for experts in the field has selected three doctors from Instituto Bernabeu for the role of scientific research reviewers. The reproductive medicine clinic participates annually in this essential gathering for leading researchers in the field of fertility by presenting scientific research on infertility, genetics and embryology, amongst others. Furthermore, Medical Co-Director of Instituto Bernabeu, Dr Joaquín Llácer, is a spokesperson on the society’s committee of representatives and the Spanish specialists’ representative at ESHRE until 2020.

Read more

The Manager of the Embryology Unit at Instituto Bernabeu addresses ova and ovarian tissue vitrification on the Master's Course in Human Reproduction given at Complutense University

  • 03/12/19

The Manager of the Embryology Unit at Instituto Bernabeu, Dr Jorge Ten, gave a lecture on the Master’s Course in Human Reproduction organised by Complutense University in Madrid (UCM) and the Spanish Fertility Society (SEF).

Read more

Instituto Bernabeu Gyneacologist addresses diagnostic guidance during the Treatment of the Sterile Partner course organised by the Spanish Society of Gynaecology and Obstetrics

  • 03/05/19

Instituto Bernabeu's gyneacologists specialised in reproductive medicine, participated in the course on Treatment of the Sterile Partner that was held on 1st March in the Madrid headquarters of the Spanish Society of Gynaecology and Obstetrics (SEGO). The training course is for gynaecologists who are interested in reproductive medicine. It is organised by the Sterility and Infertility section at SEGO and Dr Rafael Bernabeu, Vice President of SEISEGO, addressed the issue of diagnostic guidance.

Read more

Instituto Bernabeu in Albacete delivers a seminar on embryology for students of Medicine at Castilla La Mancha University

  • 02/28/19

Instituto Bernabeu in Albacete is actively involved in the community in Castilla La Mancha. Its work includes talks, workshops and courses in which staff from the reproductive medicine clinic participate. Instituto Bernabeu researchers collaborate and participate in the training courses for future specialists and they help to teach them the techniques and processes that are used in reproductive medicine.

Read more

At the 3rd Galician and Portuguese Event on Assisted Reproduction, Dr Joaquín Llácer addresses demeanour when dealing with patients who have a poor prognosis

  • 02/27/19

In February, Dr Joaquín Llácer, our Medical Co-Director, participated in two events aimed at reproductive medicine specialists. On 2nd February in the 3rd Galician and Portuguese Event on Assisted Reproduction, the gynaecologist who specialises in poor ovarian response gave a presentation addressing demeanour when dealing with patients who have a poor assisted reproduction prognosis. Spanish and Portuguese specialists gathered at the event in order to address legislative challenges, the challenges faced by reproductive medicine and some of the field’s ethical debates.

Read more

Human Reproduction highlights Instituto Bernabeu research work that addresses the influence of mitochondrial DNA on IVF results

  • 02/20/19

Human Reproduction, a scientific journal, has published research work carried out by Instituto Bernabeu that examines whether or not the number of mitochondrial DNA copies (mtDNA) in human embryos can affect pregnancy rates. The clinic is the first to have performed a comprehensive study of embryo mtDNA linked to IVF results analysing the quantity and quality of the mtDNA.

Read more

New IB Newsletter: The wait will end just the way you hoped it would. Guaranteed!

  • 02/13/19

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Pregnancy and childbirth guarantee programme or 100% reimbursment.

Read more

Do you need help? 
We can help you with a no-obligation